NSAIDs and incident Alzheimer's disease. The Rotterdam study

Neurobiology of Aging

Volumn 19, Issue 6, 1998, Pages 607-611

  In 'T Veld, B A ^a,b   Launer, L J ^a,c   Hoes, A W ^d   Ott, A ^a   Hofman, A ^a   Breteler, M M B ^a   Stricker, B H Ch ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Drug Safety Unit   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Alzheimer's disease; Nested case control study; NSAIDs

Indexed keywords

ACETYLSALICYLIC ACID; BENZODIAZEPINE DERIVATIVE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; SALICYLIC ACID DERIVATIVE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK;

EID: 0032450999     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00096-7     Document Type: Article

References (22)

1. 1. Andersen, K; Launer, L. J.; Ott, A., Hoes, A. W.; Breteler, M. M.; Hofman, A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 45:1441-1445; 1995.
2. 2. Breitner, J. C.; Gau, B. A.; Welsh, K. A.; Plassman, B. L.; McDonald, W. M.; Helms, M. J.; Anthony, J. C. Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study. Neurology 44:227-232; 1994.
3. 3. Breteler M. M. B.; Claus J. J.; van Duijn C. M.; Launer L. J.; Hofman A. Epidemiology of Alzheimer's disease. Epidemiol. Rev. 14:59-82; 1992.
4. 4. Broc, G. A.; Henderson, A. S.; Creasey, H.; McCusker, E.; Korten, A. E.; Jorm, A. E.; Longley, W.; Anthony, J. C. A case-control study of Alzheimer's disease in Australia Neurology 40:1698-1707; 1990.
5. 5. Copeland, J. R.; Kelleler M. J.; Kellett, J. M.; Gourlay, A. J.; Gurland, B. J.; Heiss, J. L.; Sharpe, L. A semi-structured clinical interview for the assessment and diagnosis of mental state in the elderly: the Geriatric Mental State Schedule. I. Development and reliability. Psychol Med 6:439-449; 1976.
6. 6. Diagnostic and Statistical Manual of Mental Disorders. 3rd edition, revised. Washington, D.C.: American Psychiatric Association; 1987.
7. 7. Eikelenboom P.; Zhan, S.-S.; van Gool, W. A.; Allsop, D. Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol. Sci. 15:447-450; 1994
8. 8. Folstein, M. F.; Folstein, S. E.; McHugh, P. R. "Mini-mental State." A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:189-198; 1975.
9. 9. French, L. R.; Schuman, L. M.; Mortimer, J. A.; Hutton, J. T.; Boatman, R. A.; Christians, B. A case-control study of dementia of the Alzheimer's type. Am. J. Epidemiol. 121:414-421; 1955.
10. 10. Graves, A. B.; White, E.; Koespell, T. D.; Reifler, B. V.; van Belle, G.; Larson, E. B.; Raskind, M. A case-control study of Alzheimer's disease. Ann. Neurol. 28:766-774; 1990.
11. 11. Guidelines for ATC Classification. Oslo: WHO Collaborating Centre for Drug Statistics Methodology-Nordic Council on Medicines; 1990.
12. 12. In T Veld, B. A.; Launer, L. J.; Hoes, A. W.; Stricker, B. H. Validation of prescription in medical records of general practitioners concerning drug use in a cohort of elderly. Pharmacoepidemiol. Drug Safety :S123 (abstract); 1997.
13. 13. Jenkinson, M. L.; Bliss, M. R.; Brain, A. T.; Scott, D. L. Rheumatoid arthritis and senile dementia of the Alzheimer's type. Br. J. Rheumatol. 28:86-88; 1989.
14. 14. McGeer, P. L.; Akiyama, H.; Itagaki, S.; McGeer E. G. Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 816(suppl 4):516-527; 1989.
15. 15. McGeer, P. L.; Harada, N.; Kimura, H.; McGeer, E. G.; Schulzer, M. Prevalence of dementia amongst elderly Japanese with leprosy: Apparent effect of chronic drug therapy. Dementia 3:146-149; 1992.
16. 16. McGeer, P. L.; McGeer, E.; Rogers, J.; Sibley, J. Anti-Inflammatory drugs and Alzheimer's disease. Lancet 335:1037; 1990.
17. 17. McKhann, G.; Drachmann, D.; Folstein, M.; Katzman, R.; Price, D.; Stadlan, E. M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Service Taskforce on Alzheimer's disease. Neurology 34:939-944; 1984.
18. 18. Myllykangas-Luosujarvi, R.; Isomaki, H. Alzheimer's disease and rheumatoid arthritis. Br. J. Rheumatol. 33:501-502; 1994.
19. 19. Ott, A.; Breteler, M. M.; van Harskantp, F.; Grobbee, D. E.; Hofman, A. The incidence of dementia in the Rotterdam Study. In: Iqbal, K.; Winhlad, B.; Nishimura, T.; Takeda, M.; Wisniewski, H. M., eds. Alzheimer's Disease: Biology, Diagnosis and Therapeutics. John Wiley & Sons Ltd.; 1997:3-10.
20. 20. Roth, M.; Tyin, E.; Mountjoy, C. Q.; Huppert, F. A.; Hendric, H.; Verma, S.; Goddard, R. CAMDEX. A standardized instrument for the diagnosis of mental disorders in the elderly with special reference to the early detection of dementia. Br. J. Psychiatry 149:698-709; 1986.
21. 21. Stewart, W. F.; Kawas, C.; Corrada, M.; Metter, E. J. Risk of Alzheimer's disease and duration of NSAID use. Neurology 48:626-632; 1997.
22. 22. Van Muiswinkel, F. L.; Eikelenboom, P. Do nonsteroidal anti-inflammatory drugs have a protective effect against dementia? Drug Aging 9:1-7; 1996.